Application 207342
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GUAIFENESIN | GUAIFENESIN | TABLET, EXTENDED RELEASE;ORAL | 600MG | No | No |
| 002 | GUAIFENESIN | GUAIFENESIN | TABLET, EXTENDED RELEASE;ORAL | 1.2GM | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207342-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | ||
| A207342-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207342-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A207342-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2018-07-11 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62011-0377 | Mucus Relief Extended Release | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 62011-0377 | Mucus Relief Extended Release | Guaifenesin | McKesson (Health Mart) | ANDA | Current |
| 62011-0378 | Mucus Relief Extended Release | Guaifenesin | McKesson (Health Mart) | ANDA | Current |
| 62011-0378 | Mucus Relief Extended Release | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 62011-0378 | Mucus Relief Extended Release | Guaifenesin | McKesson (Health Mart) | ANDA | Current |
| 62011-0378 | Mucus Relief Extended Release | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 63868-871 | Mucus Relief Extended Release | Guaifenesin | QUALITY CHOICE (Chain Drug Marketing Association) | ANDA | Current |
| 63868-871 | Mucus Relief Extended Release | Guaifenesin | QUALITY CHOICE (Chain Drug Marketing Association) | ANDA | Current |
| 63868-872 | Mucus Relief Extended Release | Guaifenesin | QUALITY CHOICE (Chain Drug Marketing Association) | ANDA | Current |
| 63868-872 | Mucus Relief Extended Release | Guaifenesin | QUALITY CHOICE (Chain Drug Marketing Association) | ANDA | Current |
| 63941-731 | Mucus Relief | Guaifenesin | Best Choice (Valu Merchandisers Company) | ANDA | Current |
| 65162-036 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-036 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-036 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-036 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-037 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-037 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-037 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-037 | Guaifenesin | Guaifenesin | Amneal Pharmaceuticals LLC | ANDA | Current |
| 67091-370 | Mucus Relief | Guaifenesin | WinCo Foods, LLC | ANDA | Current |
| 67091-370 | Mucus Relief | Guaifenesin | WinCo Foods, LLC | ANDA | Current |
| 68016-170 | Mucus Relief | Guaifenesin | Chain Drug Consortium, LLC | ANDA | Current |
| 68016-170 | Mucus Relief | Guaifenesin | Chain Drug Consortium, LLC | ANDA | Current |
| 68016-170 | Mucus Relief | Guaifenesin | Chain Drug Consortium, LLC | ANDA | Current |
| 69256-732 | Mucus Relief Extended Release | Guaifenesin | Harris Teeter, LLC | ANDA | Current |
| 69256-732 | Mucus Relief Extended Release | Guaifenesin | Harris Teeter, LLC | ANDA | Current |
| 69842-732 | Mucus Relief Extended Release | Guaifenesin | CVS Pharmacy | ANDA | Current |
| 69842-732 | Mucus Relief Extended Release | Guaifenesin | CVS Pharmacy | ANDA | Current |
| 69842-732 | Mucus Relief Extended Release | Guaifenesin | CVS Pharmacy | ANDA | Current |
| 69842-732 | Mucus Relief Extended Release | Guaifenesin | CVS Pharmacy | ANDA | Current |
| 70000-0479 | Mucus Relief Extended Release | Guaifenesin | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70000-0479 | Mucus Relief Extended Release | Guaifenesin | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70000-0479 | Mucus Relief Extended Release | Guaifenesin | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70000-0479 | Mucus Relief Extended Release | Guaifenesin | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70000-0479 | Mucus Relief Extended Release | Guaifenesin | Cardinal Health (Leader) 70000 | ANDA | Current |
| 70677-0049 | Mucus Relief | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 70677-0049 | Mucus Relief | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 70677-0049 | Mucus Relief | Guaifenesin | McKesson (Sunmark) | ANDA | Current |
| 70677-0049 | Mucus Relief | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 70677-0050 | Mucus Relief Extended-Release | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 70677-0050 | Mucus Relief Extended-Release | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 70677-0050 | Mucus Relief Extended-Release | Guaifenesin | McKesson (Sunmark) | ANDA | Current |
| 70677-0050 | Mucus Relief Extended-Release | Guaifenesin | McKesson (Sunmark) | ANDA | Current |
| 70677-0050 | Mucus Relief Extended-Release | Guaifenesin | Strategic Sourcing Services LLC | ANDA | Current |
| 82649-732 | Mucus Relief | Guaifenesin | LifeMD | ANDA | Current |